毒物动力学
代谢物
生物累积
化学
生物利用度
药理学
口服
亲脂性
基于生理学的药代动力学模型
吸收(声学)
药代动力学
生理学
肝肠循环
人体皮肤
毒理
尿
环境化学
生物浓缩
分布(数学)
体内
医学
内照射剂量
毒性
分配量
活性代谢物
代谢组
异型生物质的
毒物
光防护
毒物动力学
作者
Ruosi Li,H W Shen,Qingqing Liu,Xuanqi Zhao,Shuai Wu,Yiyi Chen,Siyu Fu,Shiyi Wang,Jing Zhan,Bing Lyu,Jingguang Li,Jiaying Liu
标识
DOI:10.1021/acs.est.6c06976
摘要
Ultraviolet absorbers (UVAs) are a group of emerging contaminants with high production volumes. Their applications include but are not limited to sunscreens and food contact materials. Dermal and oral exposures are generally regarded as the main human exposure pathways, but pathway-specific toxicokinetics of UVAs are still unclear. Here, major metabolites and pathway-specific toxicokinetics of five typical UVAs were investigated using in vitro experiments, animal administration experiments, and consecutively collected 24 h human urine. Unlike other UVAs, 2-ethylhexyl p -methoxycinnamate (EHMC) exhibited a significantly longer biological elimination half-life ( T 1/2β ) and a larger volume of distribution (Vd) following oral administration compared to dermal exposure, suggesting a potentially higher risk via the oral pathway. 2-(2 H -Benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328) showed the greatest bioaccumulation but limited systematic absorption and restricted tissue distribution for both pathways. It indicated entrapment of UV-328 in the enterohepatic circulation, which was also supported by its high lipophilicity and low metabolic rate. The oxidative metabolite of UV-328 was found to be indicative of oral exposure. Further monitoring of 24 h human urine ( n = 220 from environmentally exposed participants) shows that non-oral exposure is probably the main exposure pathway for UV-328 in the general population. In summary, this study addresses a key gap in understanding pathway-specific toxicokinetics of UVAs and provides valuable data to improve the accuracy of assessing systemic exposure levels from multiple pathways.
科研通智能强力驱动
Strongly Powered by AbleSci AI